Riskpilot← Back to searchSign inGet full accessStureOptikern AB
ABActiveOrg 5562642701Grev Turegatan 9Retail sale of medical and orthopaedic goods · NACE 4774Est. 19855-9 employees
Revenue 2024
SEK 25,8M
+11% vs 2023
EBITDA margin
19.2%
+72% vs 2023
Equity ratio
71.0%
Financial strength
Net profit 2024
SEK -109K
+68% vs 2023
| Revenue | SEK 25,8M | +11% |
| EBITDA | SEK 4,9M | +72% |
| Net profit | SEK -109K | +68% |
| Total assets | SEK 15M | -12% |
| Equity | SEK 10,7M | -1% |
| Employees | — | — |
Legal name
StureOptikern AB
Org number
5562642701
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
17 september 1985
Share capital
SEK 500 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva konsultverksamhet inom optik- och ergonomiområdet samt försäljning av därtill hörande produkter ävensom idka därmed förenlig verksamhet.
Address
Grev Turegatan 9
Phone
+4686115500
Email
accounting@memira.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 21 281 | 32 815 | 18 778 | 24 495 | 24 901 | 23 169 | 25 795 |
| Staff expenses | — | — | — | — | — | — | — | −4 491 | — | — |
| EBITDA | 3 397 | −69 | 5 688 | 5 467 | 9 471 | 4 264 | 7 884 | 6 881 | 2 870 | 4 944 |
| Depreciation & amort. | −159 | −104 | −110 | −165 | −73 | −21 | −100 | −137 | −211 | −157 |
| EBIT | 3 238 | −173 | 5 578 | 5 302 | 9 398 | 4 243 | 7 784 | 6 744 | 2 659 | 4 787 |
| Net financials | 1 140 | −9 | −17 | −20 | 51 | −11 | −29 | −82 | −64 | −55 |
| Profit before tax | 5 701 | −182 | 161 | 83 | 9 449 | −16 | −103 | −173 | −342 | −109 |
| Tax | −1 059 | −0 | −12 | −28 | −2 099 | 1 | −0 | — | −0 | −0 |
| Net profit | 4 642 | −182 | 149 | 55 | 7 350 | −15 | −103 | −173 | −342 | −109 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 940 | 9 779 | 12 934 | 17 248 | 12 636 | 19 495 | 28 002 | 33 915 | 17 026 | 15 025 |
| Equity | 5 614 | 5 432 | 5 581 | 5 636 | 8 087 | 11 399 | 11 296 | 11 123 | 10 781 | 10 672 |
| Long-term debt | 0 | 0 | 3 400 | 8 600 | 0 | 0 | 0 | — | 0 | 0 |
| Short-term debt | 2 326 | 4 347 | 3 953 | 3 012 | 4 550 | 8 081 | 16 678 | 22 728 | 6 245 | 4 353 |
| Total debt | 2 326 | 4 347 | 7 353 | 11 612 | 4 550 | 8 081 | 16 678 | 22 728 | 6 245 | 4 353 |
EBITDA margin
19.2%
This company
15.8%
Market median
+22% vs market
20152024
Equity ratio
71.0%
This company
38.2%
Market median
+86% vs market
20152024
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
20152024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20152024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20152024
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-06-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ES Chief Auditor | Chief Auditor | 2022 | — | — |
TK Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MK Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KL Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2025 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Memira AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bergman Scandinavia AB
StureOptikern AB Board members of StureOptikern AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Svenson | Chief Auditor | 0 companies |
| Tomas Karlsson | Chief Executive Officer | 0 companies |
| Johanna Maria Elisabeth Öberg | Chief Executive Officer | 0 companies |
| Mats Karl Johan Gunnarsson | Chief Executive Officer | 0 companies |
| Karl Leonard Daun | Chief Auditor | 0 companies |
| J M Christine Westerlund-Wall | Deputy Board Member | 0 companies |
| Erik Lars Karl Romell | Board of Directors | 0 companies |
| Kent Mikael Lind | Deputy Board Member | 0 companies |
| Anna Cecilia Höjgård Höök | Deputy Board Member | 0 companies |
| Lars Anders Arverud | Board of Directors | 0 companies |
| Anna Katarina Enlund | Deputy Board Member | 0 companies |